Sign in
Explore the registryTrack Jnj-69086420's trials

A Study of JNJ-69086420, an Actinium-225-Labeled Antibody Targeting Human Kallikrein-2 (hK2) for Advanced Prostate Cancer

JNJ-69086420OngoingActive not recruitingPhase 1Open NCT04644770 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…